📷 Image: Wikimedia Commons / Alok Singh Oberoi
Business
Tukaram Mundhe Unveils Action Plan on Medical Device Pricing: MRP vs Procurement Gap
✍️ Livemint
🗓 16 Sep 2026, 01:46 PM
👁 9
Tukaram Mundhe has released a new action plan highlighting the disparity between the Manufacturer's Suggested Retail Price (MRP) and procurement prices for medical devices.
Tukaram Mundhe has unveiled a comprehensive action plan aimed at addressing the pricing gap in the medical device sector. The plan focuses on the disparity between the Manufacturer's Suggested Retail Price (MRP) and the actual procurement prices paid by government and private buyers.
By highlighting the difference between MRP and procurement costs, the initiative seeks to promote greater transparency and fair pricing for essential medical equipment. The plan also calls for stricter monitoring of pricing mechanisms across the supply chain.
Stakeholders, including manufacturers, distributors, and healthcare providers, are expected to review the proposed measures and adjust their procurement strategies accordingly. The move is seen as a step toward ensuring that public and private institutions can access medical devices at cost‑effective rates.
Mundhe’s action plan will be rolled out in phases, with the first phase targeting high‑volume medical devices used in hospitals and diagnostic centers. Officials will monitor the impact and refine the guidelines based on feedback from industry participants.
By highlighting the difference between MRP and procurement costs, the initiative seeks to promote greater transparency and fair pricing for essential medical equipment. The plan also calls for stricter monitoring of pricing mechanisms across the supply chain.
Stakeholders, including manufacturers, distributors, and healthcare providers, are expected to review the proposed measures and adjust their procurement strategies accordingly. The move is seen as a step toward ensuring that public and private institutions can access medical devices at cost‑effective rates.
Mundhe’s action plan will be rolled out in phases, with the first phase targeting high‑volume medical devices used in hospitals and diagnostic centers. Officials will monitor the impact and refine the guidelines based on feedback from industry participants.